Pamidronate for early-stage, untreated myeloma

J Clin Oncol. 2003 Aug 15;21(16):3177-8; author reply 3178. doi: 10.1200/JCO.2003.99.248.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Diphosphonates / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Multiple Myeloma / drug therapy*
  • Pamidronate

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Pamidronate